Literature DB >> 31008328

Frequency of post-stroke electroencephalographic epileptiform activity - a systematic review and meta-analysis of observational studies.

Carla Bentes1,2,3, Filipe B Rodrigues4,5,6, Diana Sousa1,3, Gonçalo S Duarte4,5, Ana C Franco1, Raquel Marques4,5, Hipólito Nzwalo7, Ana R Peralta1,2,3, José M Ferro1,3, João Costa3,4,5,8,9.   

Abstract

INTRODUCTION: Cerebrovascular diseases are the most frequent risk factor for epilepsy in the elderly, and epileptic phenomenon following stroke is known to worsen the prognosis. Although electroencephalography is the gold standard epilepsy biomarker, it is rarely used in post-stroke studies, and the frequency of post-stroke epileptiform activity is still uncertain. PATIENTS AND METHODS: We analysed studies indexed to MEDLINE, Embase, Web of Science, PsycINFO and OpenGrey (up to March 2015), reporting post-stroke electroencephalographic epileptiform activity frequency in adults. Epileptiform activity was classified as ictal (electrographic seizures) and interictal (non-periodic spikes and sharp waves). Data selection, extraction and appraisal were done in duplicate. Random-effects meta-analysis was used to pool frequencies.
RESULTS: The pooled frequency of post-stroke ictal and interictal epileptiform activity was 7% (95% CI 3%-12%) and 8% (95% CI 4%-13%), respectively. The use of continuous electroencephalogram was not associated with an increased frequency of electrographic seizures (p = 0.05), nor did the management setting (Intensive Care Unit versus non- Intensive Care Unit, p = 0.31). However, studies with continuous electroencephalogram showed a higher frequency of interictal epileptiform activity (p = 0.01). DISCUSSION: This study provides the best available estimates of the frequency of post-stroke electroencephalographic epileptiform activity. Due to detection bias, it was not possible to correlate clinical and electrographic seizures.
CONCLUSION: The frequency of ictal and interictal epileptiform activity in the electroencephalogram was comparable with previous frequency analyses of clinical seizures. The frequency of ictal epileptiform activity did not change with continuous record or clinical setting, while the frequency of interictal epileptiform activity increased with continuous record.

Entities:  

Keywords:  Epileptic seizures; electroencephalogram; meta-analysis; stroke; systematic review

Year:  2017        PMID: 31008328      PMCID: PMC6453191          DOI: 10.1177/2396987317731004

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN: 2396-9873


  17 in total

Review 1.  A glossary of terms most commonly used by clinical electroencephalographers and proposal for the report form for the EEG findings. The International Federation of Clinical Neurophysiology.

Authors:  S Noachtar; C Binnie; J Ebersole; F Mauguière; A Sakamoto; B Westmoreland
Journal:  Electroencephalogr Clin Neurophysiol Suppl       Date:  1999

2.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

3.  An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Ralph L Sacco; Scott E Kasner; Joseph P Broderick; Louis R Caplan; J J Buddy Connors; Antonio Culebras; Mitchell S V Elkind; Mary G George; Allen D Hamdan; Randall T Higashida; Brian L Hoh; L Scott Janis; Carlos S Kase; Dawn O Kleindorfer; Jin-Moo Lee; Michael E Moseley; Eric D Peterson; Tanya N Turan; Amy L Valderrama; Harry V Vinters
Journal:  Stroke       Date:  2013-05-07       Impact factor: 7.914

Review 4.  American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version.

Authors:  L J Hirsch; S M LaRoche; N Gaspard; E Gerard; A Svoronos; S T Herman; R Mani; H Arif; N Jette; Y Minazad; J F Kerrigan; P Vespa; S Hantus; J Claassen; G B Young; E So; P W Kaplan; M R Nuwer; N B Fountain; F W Drislane
Journal:  J Clin Neurophysiol       Date:  2013-02       Impact factor: 2.177

5.  Epilepsy in middle-aged and elderly people: a three-year observation.

Authors:  Boguslaw Paradowski; Mieszko M Zagrajek
Journal:  Epileptic Disord       Date:  2005-06       Impact factor: 1.819

6.  Diagnostic yield of electroencephalography in the medical and surgical intensive care unit.

Authors:  Hooman Kamel; John P Betjemann; Babak B Navi; Manu Hegde; Karl Meisel; Vanja C Douglas; S Andrew Josephson
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

7.  Young adult ischaemic stroke related acute symptomatic and late seizures: risk factors.

Authors:  R Roivainen; E Haapaniemi; J Putaala; M Kaste; T Tatlisumak
Journal:  Eur J Neurol       Date:  2013-04-14       Impact factor: 6.089

8.  Continuous electroencephalography in the medical intensive care unit.

Authors:  Mauro Oddo; Emmanuel Carrera; Jan Claassen; Stephan A Mayer; Lawrence J Hirsch
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

9.  Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure.

Authors:  Dale C Hesdorffer; Emma K T Benn; Gregory D Cascino; W Allen Hauser
Journal:  Epilepsia       Date:  2009-01-26       Impact factor: 5.864

Review 10.  Detection of electrographic seizures with continuous EEG monitoring in critically ill patients.

Authors:  J Claassen; S A Mayer; R G Kowalski; R G Emerson; L J Hirsch
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

View more
  1 in total

Review 1.  Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management.

Authors:  Marian Galovic; Carolina Ferreira-Atuesta; Laura Abraira; Nico Döhler; Lucia Sinka; Francesco Brigo; Carla Bentes; Johan Zelano; Matthias J Koepp
Journal:  Drugs Aging       Date:  2021-02-23       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.